Two papers in this issue of Thorax (pp 600-603 and 672-674) support the case for using this test in regions where the incidence of tuberculosis is high (the Western Cape in South Africa -670 per 100 000)2 or moderately high (Galicia, Spain -95 per 100 000).?
Investigation of a pleural effusion demands a pleural aspiration and biopsy. Adenosine deaminase is an enzyme involved in purine catabolism found in most cells, but particularly in lymphocytes where its concentration is inversely related to the degree of differentiation. One of the earliest references to this group of enzymes evaluated its role in the diagnosis of lung cancer.'8 High levels of ADA activity were subsequently found in patients with tuberculous pleurisy.' Levels of ADA activity show a significant correlation with the number of CD4 + lymphocytes in the pleural effusion'9; false positive tests are therefore found in patients with rheumatoid disease, chronic lymphatic leukaemia, and undifferentiated lymphoma.202' Neutrophils contribute to the high levels of ADA activity found in empyema fluid. Using the data of Burgess et al,2 the variation in the positive predictive value with prevalence is shown in the figure. Clearly, where the incidence oftuberculosis greatly exceeds any other cause of a lymphocytic pleural effusion, ADA activity will have a high positive predictive value.
Two questions remain unanswered by these papers. Firstly, would ADA activity be helpful in deciding which patients should receive empirical antituberculosis chemotherapy in the 20% of pleural effusions where even a thorocoscopy or thoracotomy has not achieved a diagnosis? Such a study would require a reasonable incidence of tuberculous pleurisy and the random assignment ofpatients with high ADA activity in their pleural fluid to treatment or placebo; the frequency of active tuberculosis over the subsequent five years would be the end point. Secondly 
